| Product No | EMEA/H/C/000573 |
|---|---|
| Brand Name | Nodetrip (previously Xeristar) |
| Nonproprietary Name | duloxetine |
| API | duloxetine |
| ATC Code | N06AX21 |
| Indications | Treatment of major depressive disorder;Treatment of diabetic peripheral neuropathic pain;Treatment of generalised anxiety disorder;Xeristar is indicated in adults. |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | Esteve Pharmaceuticals, S.A. |
| Status | Withdrawn |
| Authorization Date | 2004-12-17 |
| Version | 32 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information